Skip to content

Evidence

Latest FreedomWitness coverage in this editorial section.

Evidence analysis

Breast cancer treatment: When less is more

Breast Cancer Treatment: When Less is More – Evidence Dossier Source: PLOS Medicine, October 26, 2026, article by Katarzyna Starowicz on behalf of the PLOS Medicine Staff Editors What is Established Breast cancer mortality has declined annually by…

Read →

Evidence analysis

Hannah and the Janes

What is established The American Repertory Theatre (A.R.T.) has produced a new rock opera titled 1972, which opened in late October 2026 and runs through November at Farkas Hall. The musical centers on a 19-year-old pregnant woman named…

Read →

Evidence analysis

Opinion/decision on a Paediatric investigation plan (PIP): Mounjaro, tirzepatide, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Other, PIP number: EMA/PE/0000245851

Investigations into Paediatric Use of Tirzepatide (Mounjaro): EMA PIP Modification Decision This dossier evaluates the European Medicines Agency (EMA) decision dated 11 July 2025 regarding the modification of an agreed paediatric investigation plan (PIP) for tirzepatide, marketed as…

Read →

Evidence analysis

Opinion/decision on a Paediatric investigation plan (PIP): Exblifep, Enmetazobactam,cefepime, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Infections and infestations;Infectious diseases, PIP number: EMA/PE/0000247019

Investigations into the Paediatric Investigation Plan for Exblifep (Enmetazobactam / Cefepime) This dossier reviews publicly available information regarding a modification to a Paediatric Investigation Plan (PIP) concerning the combination drug Exblifep, which contains enmetazobactam and cefepime, intended for…

Read →